Search research articles
Contact Us
Filters
Showing results (81-90 of 293) with videos related to
Page
of 30
Sort By:
Molecular Cancer Therapeutics
|
December 14, 2002
Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center
Kylie A Hotchkiss, Anthony W Ashton, Radma Mahmood, et al.
Clinical Breast Cancer
|
September 23, 2017
Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
Jesus Anampa, Alice Chen, John Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study
J A Sparano, P Hu, R M Rao, et al.
Leukemia & Lymphoma
|
November 22, 2017
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034
Carlyn Rose C Tan, Stefan K Barta, Jeannette Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
September 14, 2001
Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells
D M Lathers, N Achille, K Kolesiak, et al.
Cancer Investigation
|
May 15, 2003
A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma
Della Makower, Joseph A Sparano, Scott Wadler, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer
J A Sparano, E L Schwartz, K M Salva, et al.
Clinical Breast Cancer
|
December 11, 2012
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer
Yihong Wang, Joseph A Sparano, Susan Fineberg, et al.
Journal of the National Cancer Institute
|
February 19, 1997
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy
J A Sparano, X Hu, P H Wiernik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196
Joseph A Sparano, Patricia Bernardo, Patricia Stephenson, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 293) with videos related to
Sort By:
Page
of 30
Molecular Cancer Therapeutics
|
December 14, 2002
Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center
Kylie A Hotchkiss, Anthony W Ashton, Radma Mahmood, et al.
Clinical Breast Cancer
|
September 23, 2017
Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
Jesus Anampa, Alice Chen, John Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study
J A Sparano, P Hu, R M Rao, et al.
Leukemia & Lymphoma
|
November 22, 2017
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034
Carlyn Rose C Tan, Stefan K Barta, Jeannette Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
September 14, 2001
Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells
D M Lathers, N Achille, K Kolesiak, et al.
Cancer Investigation
|
May 15, 2003
A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma
Della Makower, Joseph A Sparano, Scott Wadler, et al.
American Journal of Clinical Oncology
|
October 1, 1990
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer
J A Sparano, E L Schwartz, K M Salva, et al.
Clinical Breast Cancer
|
December 11, 2012
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer
Yihong Wang, Joseph A Sparano, Susan Fineberg, et al.
Journal of the National Cancer Institute
|
February 19, 1997
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy
J A Sparano, X Hu, P H Wiernik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196
Joseph A Sparano, Patricia Bernardo, Patricia Stephenson, et al.
Page
of 30